positive mention on cnbc gave a little more detail
as to seac VOD niche..article below is the gist of the general commentary from the fund manager interviewed etc...:
Tech, Biotech Sectors Likely To Continue Runs
-Fund Mgr
Dow Jones Newswires
NEW YORK -- Technology and biotechnology sectors are likely to continue their positive runs for a long time, said Ken Mertz, portfolio manager of HomeState PA Growth Fund.
In a CNBC interview Thursday, Mertz said, "We think capital spending is being devoted to technology and as long as business needs to get more productive," the technology
sector will deliver.
Additionally, biotechs have severely underperformed for the past six to seven years, and the recent upswing is in the "first leg," he said.
Mertz likes Clarus Corp. (CLRS), the fund's largest holding. Clarus is an e-procurement services company that serves the middle-market area.
He also suggested Safeguard Scientifics Inc. (SFE), an Internet incubator of business-to-business plays. Even at current levels, Mertz sees the issue as a buy. He
expects that up to 10 companies currently being incubated by Safeguard will go public this year, giving Safeguard's investors a right to buy these shares.
Mertz likes Emisphere Technologies Inc. (EMIS), which is developing oral-delivery technology for previously injectable-only agents. It is in phase III trials of its oral-heparin drug.
He also likes Seachange International Inc. (SEAC).
-Beth M. Mantz; Dow Jones Newswires; 201-938-5393 |
